United States Lidocaine Patches Market

United States Lidocaine Patches Market Size Report – In a Glance

As per the survey report on United States lidocaine patches market, the market is expected to foresee a CAGR value of 5.6% during 2025-2035, and further generate a market size of USD 1011.3 million by the end of 2035. In 2025, the market size was value at USD 575.2 million revenue.

• The United States lidocaine patches market’s growth is driven by growing aging population and demand for non-opioid pain management solutions.
• KDMI analyst’s growth analysis foresees rising prevalence of chronic and neuropathic pain disorders as the growth drivers for United States lidocaine patches market.

United States Lidocaine Patches Market Analysis

Lidocaine patches are medical tools which are used to help relieve pain. These patches work as local anesthetics that numbs nerves in a specific area of the body and are easily available over the counter (OTC) at local pharmacies. Lidocaine patches contain 4% lidocaine and are applied for minor pain conditions like insect bite, minor burns, and back pain. The United States lidocaine patches market growth is driven by growing aging population and demand for non-opioid pain management solutions in the industry. According to the reports by Symphony Healthcare, in 2024, there were over 206 million prescriptions for lidocaine patches were sold in the United States, due to the rising incidence of painful arthritic disorder. Amneal Pharmaceuticals LLC, Viatris Inc, and Teikoku Pharma are some of the significant participants in the United States lidocaine patches market.

United States Lidocaine Patches Market Growth Drivers and Restraints

Growth Drivers

• Rising prevalence of chronic and neuropathic pain disorders – The United States lidocaine patches market growth is driven by increasing incidence of chronic and neuropathic pain conditions like arthritis, diabetic neuropathy, post-herpetic pain, and muscuskeletal pain. With the growing aging population in the region and rising lifestyle-related health issues, the demand for effective pain management solutions is rapidly growing and patients are seeking for quick and accessible solutions. Lidocaine patches are widely used for pain relief at the affected area and doesn’t need any kind of medications, which makes lidocaine patches most preferable by both patients and health professionals. This convenient solution, provides effective care to patients and results in growing awareness of high-quality pain management solutions, contributing to the market growth.
• Increased adoption of non-opioid pain management – With the growing awareness among patients about non-opioid pain management solutions in the market has increased the demand for lidocaine patches which drives the market growth. Lidocaine patches are convenient and reliable solution as they deliver targeted relief with minimal systemic absorption, which improves safety concerns and reduce side effects from opioids. Healthcare professionals are increasingly prescribing such innovative pain management solutions with integrated convenient solutions and also rising patient awareness about replacing opioids with more safer and effective solutions. This results in overall market growth and increased adoption of lidocaine patches.

Restraints

• Regulatory challenges – The United States lidocaine patches market face restraint due to stricter regulations imposed by FDA regarding safety, efficacy, and quality issues. Stricter regulations limits market opportunities for new entrants in the lidocaine patches industry and requires higher investment in research and development to adopt advanced pain management solutions which discourages small and medium health centers to adopt such innovative solutions. This factor slowdowns market growth and impacts the reach of innovative pain management solutions to patients.

United States Lidocaine Patches Market Segmentation

Our experts at KD Market Insights have segmented the United States lidocaine patches market research report as:

Analyst’s Observation on United States Lidocaine Patches Market Recent Developments

Over the years, the experts at KD Market Insights have been observing the recent developments associated with United States lidocaine patches market trends. Our expert’s market forecast analysis has recorded the market players adopting plentiful of key strategies including new product launches, mergers & acquisitions, and collaborations.

Teikoku Pharma USA has announced that the NMPA has approved Lidoderm for the treatment of Post Herpetic Neuralgia (PHN) in China. Lidoderm is designed to offer a topical and a non-systemic approach for treating neuropathic pain symptoms associated with PHN. It can be applied by following a once daily 12 hours on 12/ hours off application schedule.

Yaral Pharma Inc has announced the launch of Lidocaine Patch 5%, an AB-rated equivalent to Lidoderm. The launch is company’s prescription strength lidocaine in its latest addition to pain and inflammation portfolio that includes medication helping to meet growing demand for non-opioid prescription products.

United States Lidocaine Patches Market Competitive Landscape

Some of the significant participants who top the United States lidocaine patches market share:

• Amneal Pharmaceuticals LLC
• Endo Pharmaceuticals Inc
• Hisamitsu America Inc
• Medline Industries, LP
• Scilex Pharmaceuticals Inc
• Sparsha Pharma USA
• Teikoku Pharma
• Teva Pharmaceuticals USA, Inc
• Viatris Inc
• YARAL Pharma Inc